# The Maraviroc Central Nervous System (CNS) Study

> **NCT00982878** · PHASE1 · COMPLETED · sponsor: **Imperial College London** · enrollment: 13 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Maraviroc

## Key facts

- **NCT ID:** NCT00982878
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-07
- **Final completion:** 2011-02
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2019-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982878, "The Maraviroc Central Nervous System (CNS) Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00982878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*